Tx for Asthma and COPD Flashcards
Albuterol:
Drug Class
Use
MOA
AE/Contras
- Beta2 Agonist (quick onset, short duration)
- For acute exacerbation
- Increases cAMP lvls (bronchiodilation), inhibit macrophage-mediate inflammation and vasc. permeabilty, increased cilia motion
- AEs: N/V, Tachycardia (=> tremors), arhythmias, Hypokalemia, CNS tox, dry mouth/throat
Contra: w/ Rx => hypokalemia (beta-blockers, loop and thiazide diuretics, w/ Rx => Prolonged QT
Levabuterol:
Drug Class
Use
MOA
AE/Contras
- Beta2 Agonist (quick onset, short duration)
- For acute exacerbation
- Increases cAMP lvls (bronchiodilation) inhibit macrophage-mediate inflammation and vasc. permeabilty, increased cilia motion
- Same as albuterol but Less likely to cause Tachycardia
Terbutaline
Drug Class
Use
MOA
AE/Contras
- IV Beta2 Agonist (quick onset, short duration)
- For acute exacerbation
- Increases cAMP lvls (bronchiodilation), inhibit macrophage-mediate inflammation and vasc. permeabilty, increased cilia motion
- AEs: N/V, Tachycardia (=> tremors), arhythmias, Hypokalemia, CNS tox, dry mouth/throat
Contra: w/ Rx => hypokalemia (beta-blockers, loop and thiazide diuretics, w/ Rx => Prolonged QT
Long-acting Beta2-agonists:
Name
Use
MOA
AE/Contras
Salmeterol; Formoterol (+steriods!)
- Prophylaxis for exacerbation
- Increases cAMP lvls (bronchiodilation), inhibit macrophage-mediate inflammation and vasc. permeabilty, increased cilia motion
- AEs: N/V, Tachycardia (=> tremors), arhythmias, Hypokalemia, CNS tox, dry mouth/throat
Contra: w/ Rx => hypokalemia (beta-blockers, loop and thiazide diuretics, w/ Rx => Prolonged QT
Anti-cholinergics
Name
Use
MOA
AE/Contras
Atropine, Ipratropium, Tiotropium (long-acting and selective)
- competitively block ach from muscarinic receptors => inhibiting bronchoconstriction, decreasing mucus, enhance beta2-bronchodilation, and reduce airway remodeling (Tiotropium)
- AEs: Pupillary dilation, cycloplegia (paralysis of ciliary eye muscles), urinary retention, constipation, dry mouth,
Combivent
Class
Use
MOA
AE/Contras
Anticholinergic and B2-agonist combo
- Indicated for COPD
- Combo of two drugs
- AEs: Combo
Methylxanthines
Name
Use
MOA
AE/Contras
Theophylline and Aminophylline (caffeine family)
- 2nd line bronchodilators
- Phosphodiesterase inhibitors (less cAMP degradation), block adenosine receptors (CV effects)
- AEs; 20ug/ml - Hypokalemia, Hyperglycemia, Tachycardia, other CV and CNS tox
- *CYP interactions
Cromolyn Sodium
Use
MOA
AE/Contras
Exercise and antigen-inhaled asthma (reduces bronchial hyperactivity)
- Inhibits: mast cell degranulation, eosinophil inflamm response, cough (suppresses nerve impulses)
- AE: Taste bad, irritates trachea => bronchospasm and cough, Rarely - chestpain, restlessness, N/V, CNS depression, seizures
Glucocorticoids
Name
Use
Budesonide, fluticasone, mometasone, belcomethasone, Prednisone (PO), Prednisolone, Methylprednisolone, Dexamethasone (PO or IV)
- for both short term and long term tx of Asthma
Glucocorticoids
MOA
- Decrease production of inflammatory cytokines (inhibit NF-kB and Phospholipase A2)
- activate anti-inflammatory genes (Via GRE activation); reduce bronchial hyperactivity, enhance effect of B2-agonists
- Decrease mucus
- Inhibit IL-5 and GATA-3 => inhibition of Th2 differentiation
Glucocorticoids
AEs and Contras:
Inhaled AEs:
- Orophararngeal Candidiasis! Hoarseness and dry mouth
- decrease bone density in young women and growth rate in children
Oral AEs:
- Glucose intolerance
- Inc BP and weight
- Cataracts
- Immunosuppression!
- Cushingoid syndrome (abdom weight gain, moon face, neck buffalo hump)
Leukotriene Blockers
Name
Use
MOA
AEs
Montelukast, Zafirlukast (Receptor blockers)
- effective in asprin-induced asthma (more AA goes down LT pathway)
- block LTD4 receptors => dec bronchial reactivity and bronchoconstriction; dec mucosal secretion; dec airway inflammation
AEs
M- GI distress, laryngitis/pharyngitis, sinusitis, viral infections
Z- GI, HA, elevated liver enzymes
Leukotriene synthesis inhibitor
Name
MOA
AEs
Zileuton
- inhibit 5-lipooxygenase (AA –> LTs)
- AEs: Increased liver enzymes, CYP inhibitor
Anti-IgE drugs
Use
Name
MOA
AEs
Omalizumab
- long term asthma control when resistant to steroids and LABA
- prevent mast cell degranulation (binds IgE and preventing recognition by FceRI
- AEs: Allergic rxns, CV complications